Page 318 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer
P. 318

Appendix Table C1.14. Treatment characteristics—changes in treatment patterns over time (continued)
                                        Author                Database         Treatment          1980-     1985-89        1990-94        1995-     2000-04      2005-     Statistical          Notes
                                        Year                                                      84                                      99                     10        analysis
                                        PMID
                                              36
                                        Harlan                SEER             RP                 11.0%                    32.3%                                           P<0.001              Additional
                                        1995                                   RT                 27.0%                    29.7%                                           (chi-square test)    information is
                                        7799048                                Other              NR                       NR                                                                   presented in
                                                                               (including, ADT    (1984)                   (1991)                                                               Figures 1-4 of
                                                                               or careful                                                                                                       the paper
                                                                               observation                                                                                                      (1984-91).
                                                                               with therapy
                                                                               reserved for
                                                                               clinical
                                                                               progression)
                                                                               Age-adjusted
                                                                               proportions for
                                                                               initial Tx (within
                                                                               4 mo of
                                                                               diagnosis)
                                             41
                                        Miller                SEER             EM/ADT                                                               20.0%                  P=0.042              Higher-risk
                                             a
                                        2006                                   RP                                                                   43.1%                  (overall chi-        patients were
                                        16912266                               RT                                                                   36.9%                  square test for      those with
                                                                               [higher-risk]                                                        (2001)                 2000-02)             poorly diff.
                                                                                                                                                                                                tumors
                                                                                                                                                                                                regardless of
                                                                                                                                                                                                age or those
                                                                                                                                                                                                with
                                                                                                                                                                                                moderately
                                                                                                                                                                                                diff. tumors
                                                                                                                                                                                                aged <70 yr.
















                                        a  The study reported data for the period 2000-02, which fits entirely in one of our table’s 5 yr bins. We extracted data for the midpoint of the study period (i.e.,
                                        2001) along with the p-value from tests comparing the frequency of treatments across all 3 study years. Readers are referred to the full text of the paper for
                                        additional information.




                                                                                                                        C-77
   313   314   315   316   317   318   319   320   321   322   323